Gary Gellerman

Jerusalem, JM 40700, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

Peptide-drug conjugates bearing an antimitotic Ahx-DA1 payload achieve potent antitumor activity in Her2-amplified and EGFR-positive KRAS-mutant cancers in vivo.

Peptide-drug conjugates bearing an antimitotic Ahx-DA1 payload achieve potent antitumor activity in Her2-amplified and EGFR-positive KRAS-mutant cancers in vivo.

Journal: Bioorganic & medicinal chemistry
Published: February 17, 2026

Toward targeting the untargetable: A non-canonical EGFR-peptide-drug conjugate achieves potent antitumor activity in KRAS-mutant CRC.

Toward targeting the untargetable: A non-canonical EGFR-peptide-drug conjugate achieves potent antitumor activity in KRAS-mutant CRC.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 20, 2026

Iodinated Near-Infrared Dyes as Effective Photosensitizers for the Photodynamic Eradication of Amphotericin B-Resistant Candida Pathogens.

Iodinated Near-Infrared Dyes as Effective Photosensitizers for the Photodynamic Eradication of Amphotericin B-Resistant Candida Pathogens.

Journal: Molecules (Basel, Switzerland)
Published: November 06, 2025

Applying Unbiased, Functional Criteria Allows Selection of Novel Cyclic Peptides for Effective Targeted Drug Delivery to Malignant Prostate Cancer Cells.

Applying Unbiased, Functional Criteria Allows Selection of Novel Cyclic Peptides for Effective Targeted Drug Delivery to Malignant Prostate Cancer Cells.

Journal: Pharmaceutics
Published: April 10, 2025

Novel Cyclic Peptide-Drug Conjugate P6-SN38 Toward Targeted Treatment of EGFR Overexpressed Non-Small Cell Lung Cancer.

Novel Cyclic Peptide-Drug Conjugate P6-SN38 Toward Targeted Treatment of EGFR Overexpressed Non-Small Cell Lung Cancer.

Journal: Pharmaceutics
Published: November 12, 2024

Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia.

Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia.

Journal: Scientific reports
Published: September 05, 2024

Antineoplastic effect of doxorubizen in vitro in continuous and primary human anaplastic thyroid cancer cells.

Antineoplastic effect of doxorubizen in vitro in continuous and primary human anaplastic thyroid cancer cells.

Journal: Endocrine
Published: September 02, 2024

Sonodynamic Therapy for HER2+ Breast Cancer with Iodinated Heptamethine Cyanine-Trastuzumab Conjugate.

Sonodynamic Therapy for HER2+ Breast Cancer with Iodinated Heptamethine Cyanine-Trastuzumab Conjugate.

Journal: International journal of molecular sciences
Published: August 22, 2024

Synthesis and anticancer properties of novel dolastatin 10 analogs featuring five-membered heterocyclic rings with a linkable group at the C-terminus.

Synthesis and anticancer properties of novel dolastatin 10 analogs featuring five-membered heterocyclic rings with a linkable group at the C-terminus.

Journal: Bioorganic & medicinal chemistry
Published: February 21, 2024

Synthesis and biological evaluation of theranostic Trastuzumab-SN38 conjugate for Near-IR fluorescence imaging and targeted therapy of HER2+ breast cancer.

Synthesis and biological evaluation of theranostic Trastuzumab-SN38 conjugate for Near-IR fluorescence imaging and targeted therapy of HER2+ breast cancer.

Journal: European journal of medicinal chemistry
Published: January 28, 2023

Effect of Solubilizing Group on the Antibacterial Activity of Heptamethine Cyanine Photosensitizers.

Effect of Solubilizing Group on the Antibacterial Activity of Heptamethine Cyanine Photosensitizers.

Journal: Pharmaceutics
Published: November 06, 2022

Novel Cyclic Peptides for Targeting EGFR and EGRvIII Mutation for Drug Delivery.

Novel Cyclic Peptides for Targeting EGFR and EGRvIII Mutation for Drug Delivery.

Journal: Pharmaceutics
Published: June 07, 2022
Showing 1-12 of 44

Last Updated: 09/26/2026